APA

Brown S. P., Dransfield P., Vimolratana M., Zhu L., Luo J., Zhang J., Jiao X., Pattaropong V., Wong S., Zhuang R., Swaminath G., Houze J. B. & Lin D. C. (2018). Discovery of AM-6226: A Potent and Orally Bioavailable GPR40 Full Agonist That Displays Efficacy in Nonhuman Primates. : ACS medicinal chemistry letters.

Chicago

Brown Sean P, Dransfield Paul, Vimolratana Marc, Zhu Liusheng, Luo Jian, Zhang Jane, Jiao XianYun, Pattaropong Vatee, Wong Simon, Zhuang Run, Swaminath Gayathri, Houze Jonathan B and Lin Daniel C-H. 2018. Discovery of AM-6226: A Potent and Orally Bioavailable GPR40 Full Agonist That Displays Efficacy in Nonhuman Primates. : ACS medicinal chemistry letters.

Harvard

Brown S. P., Dransfield P., Vimolratana M., Zhu L., Luo J., Zhang J., Jiao X., Pattaropong V., Wong S., Zhuang R., Swaminath G., Houze J. B. and Lin D. C. (2018). Discovery of AM-6226: A Potent and Orally Bioavailable GPR40 Full Agonist That Displays Efficacy in Nonhuman Primates. : ACS medicinal chemistry letters.

MLA

Brown Sean P, Dransfield Paul, Vimolratana Marc, Zhu Liusheng, Luo Jian, Zhang Jane, Jiao XianYun, Pattaropong Vatee, Wong Simon, Zhuang Run, Swaminath Gayathri, Houze Jonathan B and Lin Daniel C-H. Discovery of AM-6226: A Potent and Orally Bioavailable GPR40 Full Agonist That Displays Efficacy in Nonhuman Primates. : ACS medicinal chemistry letters. 2018.